Cairo - Mubasher: The re-election of the President of Egypt, Abdel fattah El-Sisi will be broadly positive for Egypt's pharmaceutical and healthcare sector, with policy continuity and further reform momentum favourable for multinational manufacturers’ opportunities, according to a recent report by BMI Research of Fitch Group.
The Egyptian Ministry of Health is taking an increasingly active role in developing the country's pharmaceutical and healthcare sectors, according to the BMI report.
The Egyptian government aims at increasing healthcare access, pursuing policy changes to increase the country's attractiveness to foreign investors.
